These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8892364)

  • 1. Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin.
    Salokorpi T; Eronen M; von Wendt L
    Neuropediatrics; 1996 Aug; 27(4):174-7. PubMed ID: 8892364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.
    Doyle NM; Gardner MO; Wells L; Qualls C; Papile LA
    J Perinatol; 2005 May; 25(5):336-40. PubMed ID: 15861198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor.
    Eronen M; Pesonen E; Kurki T; Teramo K; Ylikorkala O; Hallman M
    J Pediatr; 1994 May; 124(5 Pt 1):782-8. PubMed ID: 8176569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin tocolysis and white matter injury in preterm infants.
    Friedman S; Flidel-Rimon O; Steinberg M; Shinwell ES
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):87-91. PubMed ID: 16203592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preterm delivery after indomethacin. A risk factor for neonatal complications?
    Gardner MO; Owen J; Skelly S; Hauth JC
    J Reprod Med; 1996 Dec; 41(12):903-6. PubMed ID: 8979204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function.
    Wurtzel D
    Obstet Gynecol; 1990 Oct; 76(4):689-92. PubMed ID: 2216206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of long-term tocolysis with indomethacin.
    Gerson A; Abbasi S; Johnson A; Kalchbrenner M; Ashmead G; Bolognese R
    Am J Perinatol; 1990 Jan; 7(1):71-4. PubMed ID: 2294913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental outcome of infants exposed to indomethacin antenatally.
    al-Alaiyan S; Seshia MM; Casiro OG
    J Perinat Med; 1996; 24(4):405-11. PubMed ID: 8880639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal phenobarbital therapy and neonatal outcome. II: Neurodevelopmental outcome at 36 months.
    Shankaran S; Woldt E; Nelson J; Bedard M; Delaney-Black V
    Pediatrics; 1996 May; 97(5):649-52. PubMed ID: 8628601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor.
    Kurki T; Eronen M; Lumme R; Ylikorkala O
    Obstet Gynecol; 1991 Dec; 78(6):1093-7. PubMed ID: 1945214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure.
    Tarcan A; Gürakan B; Yildirim S; Ozkiraz S; Bilezikçi B
    J Perinat Med; 2004; 32(1):98-9. PubMed ID: 15008397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal betamethasone and fetal growth in prematurely born children: implications for temperament traits at the age of 2 years.
    Pesonen AK; Räikkönen K; Lano A; Peltoniemi O; Hallman M; Kari MA
    Pediatrics; 2009 Jan; 123(1):e31-7. PubMed ID: 19074961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical growth and neurodevelopmental outcome of nonhandicapped low-risk children born preterm.
    Pietz J; Peter J; Graf R; Rauterberg-Ruland I; Rupp A; Sontheimer D; Linderkamp O
    Early Hum Dev; 2004 Sep; 79(2):131-43. PubMed ID: 15324993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow up of children exposed in utero to nifedipine or ritodrine for the management of preterm labour.
    Houtzager BA; Hogendoorn SM; Papatsonis DN; Samsom JF; van Geijn HP; Bleker OP; van Wassenaer AG
    BJOG; 2006 Mar; 113(3):324-31. PubMed ID: 16487205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor.
    Butler-O'Hara M; D'Angio CT
    J Perinatol; 2002; 22(7):541-6. PubMed ID: 12368969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine-exposed children: follow-up through 30 months.
    Hurt H; Brodsky NL; Betancourt L; Braitman LE; Malmud E; Giannetta J
    J Dev Behav Pediatr; 1995 Feb; 16(1):29-35. PubMed ID: 7730454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The controversy surrounding indomethacin for tocolysis.
    Macones GA; Marder SJ; Clothier B; Stamilio DM
    Am J Obstet Gynecol; 2001 Feb; 184(3):264-72. PubMed ID: 11228471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.
    Van De Water M; Kessel ET; De Kleine MJ; Oei SG
    Acta Obstet Gynecol Scand; 2008; 87(3):340-5. PubMed ID: 18307075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental assessment of prematurely born children exposed to antenatal corticosteroids.
    Arad I; Bromiker R
    Isr Med Assoc J; 2003 Sep; 5(9):659-61. PubMed ID: 14509158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.